ASCENTAGE-B (06855) plans to sell 7.325 million American Depositary Shares.
AsiaPharm-B (06855) announced that on January 23, 2025 (Eastern Time) or 202...
ASCENTAGE-B (06855) announces that on January 23, 2025 (Eastern Time in the United States) or January 24, 2025 (Hong Kong time, before the trading session on the Stock Exchange of Hong Kong), the company entered into a subscription agreement with underwriters. According to this agreement, the company will issue 7.325 million American Depositary Shares (representing a total of 29.3 million shares of underlying stock with a total face value of $2930). Each American Depositary Share represents 4 newly issued ordinary shares of the underlying stock. The company also grants the underwriters a 30-day option to purchase up to an additional 1.0988 million American Depositary Shares (representing a total face value of $439.5) at a price equal to the initial public offering price minus the underwriting discount and commission. The offering price per American Depositary Share is $17.25.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


